Jul 03, 2020
The Age: Starpharma CEO Dr Jackie Fairley on Australia’s need to turn homegrown research into commercial products
The Age interviewed Starpharma CEO Dr Jackie Fairley about how the COVID-19 pandemic could be the much needed catalyst for the pharmaceutical industry to improve the way they convert important research into commercial products. Dr Fairley also covered Starpharma’s recent activities in response to the pandemic including, the development of a nasal spray product using the antiviral dendrimer, SPL7013.
To read the full interview click here.